Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory diarrhea SAN FRANCISCO,…

Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch

Canalevia ™ -CA1 is the first and only oral prescription herbal drug candidate for CID in dogsJaguar launches awareness-raising competition in honor of International Jaguar Day; click here enter SAN…

Jaguar Well being Gives Updates on Canalevia (Crofelemer), the First Plant-based Prescription Drugs Underneath Improvement for Chemotherapy-induced Diarrhea in Canines and Train-induced Diarrhea in Canines

Step onto Wall Street with StreetInsider Premium. Request your 1-week free trial here. Canalevia would be the first and only FDA-approved herbal medicine for dogs suffering from diarrhea while on…

Jaguar Well being Supplies Updates on Canalevia (Crofelemer), the First Plant-based Prescription Drugs Underneath Growth for Chemotherapy-induced Diarrhea in Canines and Train-induced Diarrhea in Canines

Canalevia would be the first and only FDA-approved herbal medicine for dogs suffering from diarrhea while on chemotherapy Canalevia will be available through the fourth quarter of 2021, subject to…